Merck & Co. Inc. | Ownership
Companies that own Merck & Co. Inc.
The Vanguard Group, Inc.
197,937,446
7.44%
3,207,400
0.44%
06/30/2018
BlackRock Fund Advisors
122,463,625
4.61%
-7,463,631
0.42%
06/30/2018
SSgA Funds Management, Inc.
109,400,038
4.11%
-2,730,943
0.56%
06/30/2018
Capital Research & Management Co. (World Investors)
104,997,673
3.95%
15,288,378
1.01%
06/30/2018
Wellington Management Co. LLP
74,299,418
2.79%
-1,743,422
0.95%
06/30/2018
T. Rowe Price Associates, Inc.
42,618,526
1.6%
1,420,224
0.4%
06/30/2018
Northern Trust Investments, Inc.
32,788,811
1.23%
-529,942
0.5%
06/30/2018
Geode Capital Management LLC
30,700,659
1.14%
319,906
0.53%
06/30/2018
Norges Bank Investment Management
28,509,598
1.07%
891,940
0.27%
12/31/2017
JPMorgan Investment Management, Inc.
27,612,846
1.04%
4,841,121
0.61%
06/30/2018
| Address |
2000 Galloping Hill Road
Kenilworth New Jersey 07033
United States
|
|
Employees
|
- |
| Website |
http://www.merck.com |
| Updated |
07/08/2019 |
| Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. |
